Suppr超能文献

男性不育症的治疗方法和精子发生的诱导。

Approach to male infertility and induction of spermatogenesis.

机构信息

University of Washington Medical Center, Department of Medicine, 1959 NE Pacific Street, Seattle, Washington 98195, USA.

出版信息

J Clin Endocrinol Metab. 2013 Sep;98(9):3532-42. doi: 10.1210/jc.2012-2400.

Abstract

Male subfertility is common, and it causes significant duress to couples. Although the most common cause of male subfertility is idiopathic failure of spermatogenesis, a significant percentage of male subfertility is medically treatable. Compared to reproductive specialists, endocrinologists may see a population of men that have a higher prevalence of treatable causes of subfertility including sexual disorders, endocrinopathies, obesity, drugs, and ejaculatory dysfunction. Seminal fluid analysis is the most important diagnostic study, and at least 2 samples should be analyzed. All patients with sperm concentrations < 10 million/mL due to idiopathic spermatogenic defects should be referred for genetic counseling and karyotyping; most experts also recommend that these patients be tested for Y chromosomal microdeletions. For most men with low sperm concentrations due to gonadotropin deficiency, gonadotropin therapy effectively increases spermatogenesis. The endocrinologist must recognize when to use medical therapy to stimulate spermatogenesis and when to refer for consideration of assisted reproductive technology.

摘要

男性不育症较为常见,会给夫妻双方带来沉重的压力。尽管导致男性不育症的最常见原因是特发性生精功能障碍,但仍有相当比例的男性不育症可以通过医学手段治疗。与生殖专家相比,内分泌学家可能会遇到更多患有可治疗病因的男性不育症患者,这些病因包括性功能障碍、内分泌疾病、肥胖、药物和射精功能障碍等。精液分析是最重要的诊断研究,至少应分析 2 个样本。所有因特发性生精障碍导致精子浓度<1000 万/ml 的患者都应转介进行遗传咨询和核型分析;大多数专家还建议这些患者检测 Y 染色体微缺失。对于大多数因促性腺激素缺乏导致精子浓度低的男性,促性腺激素治疗可有效增加生精功能。内分泌学家必须认识到何时使用医学疗法刺激生精,并何时转介考虑辅助生殖技术。

相似文献

1
Approach to male infertility and induction of spermatogenesis.
J Clin Endocrinol Metab. 2013 Sep;98(9):3532-42. doi: 10.1210/jc.2012-2400.
2
Male infertility.
Lancet. 2021 Jan 23;397(10271):319-333. doi: 10.1016/S0140-6736(20)32667-2. Epub 2020 Dec 10.
3
Y chromosome microdeletions and alterations of spermatogenesis, patient approach and genetic counseling.
Ann Endocrinol (Paris). 2014 May;75(2):112-4. doi: 10.1016/j.ando.2014.04.001. Epub 2014 Apr 29.
5
Clinical, genetic, biochemical, and testicular biopsy findings among 1,213 men evaluated for infertility.
Fertil Steril. 2017 Jan;107(1):74-82.e7. doi: 10.1016/j.fertnstert.2016.09.015. Epub 2016 Oct 25.
6
Approach to the infertile man.
J Clin Endocrinol Metab. 2007 Jun;92(6):1995-2004. doi: 10.1210/jc.2007-0634.
8
Causes of male infertility: a 9-year prospective monocentre study on 1737 patients with reduced total sperm counts.
Hum Reprod. 2017 Jan;32(1):18-31. doi: 10.1093/humrep/dew284. Epub 2016 Nov 17.
10
Clinical review 100: Evaluation and treatment of the infertile couple.
J Clin Endocrinol Metab. 1998 Dec;83(12):4177-88. doi: 10.1210/jcem.83.12.5296.

引用本文的文献

2
Interleukin-6 in Seminal Plasmas of Azoospermic and Severe Oligo-Astheno-Teratozoospermic Patients.
Iran J Public Health. 2025 Mar;54(3):624-633. doi: 10.18502/ijph.v54i3.18256.
4
Medical treatment prior to micro-TESE.
Asian J Androl. 2025 May 1;27(3):342-354. doi: 10.4103/aja202492. Epub 2024 Dec 24.
5
The Molecular Basis of Male Infertility in Obesity: A Literature Review.
Int J Mol Sci. 2023 Dec 22;25(1):179. doi: 10.3390/ijms25010179.
7
Reproductive axis ageing and fertility in men.
Rev Endocr Metab Disord. 2022 Dec;23(6):1109-1121. doi: 10.1007/s11154-022-09759-0. Epub 2022 Nov 2.
8
Differentiation of Human Wharton Jelly Mesenchymal Stem Cells into Germ-Like Cells; emphasis on evaluation of Germ-long non-coding RNAs.
Mol Biol Rep. 2022 Dec;49(12):11901-11912. doi: 10.1007/s11033-022-07961-6. Epub 2022 Oct 15.

本文引用的文献

1
Combined effects of the variants FSHB -211G>T and FSHR 2039A>G on male reproductive parameters.
J Clin Endocrinol Metab. 2012 Oct;97(10):3639-47. doi: 10.1210/jc.2012-1761. Epub 2012 Jul 12.
2
European Association of Urology guidelines on Male Infertility: the 2012 update.
Eur Urol. 2012 Aug;62(2):324-32. doi: 10.1016/j.eururo.2012.04.048. Epub 2012 May 3.
3
Reproductive technologies and the risk of birth defects.
N Engl J Med. 2012 May 10;366(19):1803-13. doi: 10.1056/NEJMoa1008095. Epub 2012 May 5.
4
Male fertility, obesity, and bariatric surgery.
Reprod Sci. 2012 Aug;19(8):778-85. doi: 10.1177/1933719112440053. Epub 2012 Apr 25.
5
Obesity and increased risk for oligozoospermia and azoospermia.
Arch Intern Med. 2012 Mar 12;172(5):440-442. doi: 10.1001/archinternmed.2011.1382.
6
Empirical medical therapy for idiopathic male infertility: a survey of the American Urological Association.
J Urol. 2012 Mar;187(3):973-8. doi: 10.1016/j.juro.2011.10.137. Epub 2012 Jan 20.
7
The management of retrograde ejaculation: a systematic review and update.
Fertil Steril. 2012 Feb;97(2):306-12. doi: 10.1016/j.fertnstert.2011.11.019. Epub 2011 Dec 15.
9
Toward a pharmacogenetic approach to male infertility: polymorphism of follicle-stimulating hormone beta-subunit promoter.
Fertil Steril. 2011 Dec;96(6):1344-1349.e2. doi: 10.1016/j.fertnstert.2011.09.034. Epub 2011 Oct 13.
10
Clinical diagnostic testing for the cytogenetic and molecular causes of male infertility: the Mayo Clinic experience.
J Assist Reprod Genet. 2011 Nov;28(11):1091-8. doi: 10.1007/s10815-011-9633-6. Epub 2011 Sep 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验